Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-23

Clinical Trial Update: The Role of Prostaglandins in the Progression of Diabetic Retinopathy [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the role of prostaglandins in diabetic retinopathy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University | Conditions: Inflammation | Phase 1 | Status: WITHDRAWN